Customs Search

RADIOACTIVE SOURCE WIRE FOR USE IN THE DELIVERY OF HIGH DOSE RATE (HDR) BRACHYTHERAPY CANCER TREATMENT. IRIDIUM-192 SOURCE INTEGRALLY ENCAPSULATED IN A SUPER-ELASTIC ANNEALED NITIONOL (NICKEL-TITANIUM) WIRE WITH PLUGGED AND WELDED END. DISTANCE FROM DISTAL WIRE TIP TO ACTIVE SOURCE: 1MM. WIRE DIAMETER: 0.59MM. USABLE WIRE LENGTH:150CM. VALUE USD 3,900.

COBALT 60 DOUBLE ENCAPSULATED. COBALT 60 IS A SYNTHETIC RADIOACTIVE ISOTOPE OF COBALT. IT IS USED IN THE STERILISATION OF MEDICAL PRODUCTS / DEVICES.

THIS IS A DIAGNOSTIC RADIO PHARMACEUTICAL iodinated 1-125 albumin injection. FOR HUMAN PATIENTS. IT IS STERILE , NONPYROGENIC, ACQUEOUS SOLUTION FOR INTRAVENOUS USE. EACH ML PROVIDES APPROXIMATELY 10MG PROTEIN ( NORMAL HUMAN SERUM ALBUMIN), 16 MG GUANIDINE HYDROCHLORIDE FOR ISOTONICITY AND 9 MG BENZYL ALCOHOL AS A PRESERVATIVE. IT IS PREPARED FROM BLOOD THAT WAS NON ACTIVE WHEN TESTED FOR HEPATITIS B SURFACE ANTIGEN AND HIV ANTIBODY. IODINE 125 DECAYS BY ELECTRON CAPTURE WITH PHYSICAL HALF LIFE OF 60.14 DAYS. IT IS INDICATED FOR USE IN THE DETERMINATION OF TOTAL BLOOD AND PLASMA VOLUME. THE DOSE IS INJECTED INTO A LARGE VEIN IN PATIENTS ARM. MEASURE THE RESIDUAL RADIOACTIVITY IN THE SYRINGE AND NEEDLE. IODINATED 1-125 ALBUMIN INJECTION IS AVAILABLE IN MULTIPLE DOSE VIALS.

A GELATIN CAPSULE USED FOR DIAGNOSIS AND TREATMENT OF DISEASE. IT CONTAINS SODIUM IODIDE-131 SOLUTION ABSORBED ONTO A PARTLY DEHYDRATED DISODIUM HYDROGEN PHOSPATE AS AN INERT CARRIER. THE MATERIAL IS MADE RADIO ACTIVE EITHER FROM BOMBARDMENT WITHIN A CYCLOTRON OR BY IRRADIATION WITHIN A NUCLEAR REACTOR. APPLICATIONS FOR USE INCLUDE THE TREATMENT OF HYPERTHYROIDISM WHERE SURGERY IS CONTRA INDICATED AND FOR THE ELIMINATION OF RESIDUAL THYROID ACTIVITY AFTER THYROIDECTOMY IN CASES OF THYROID CARCINOMA. THE CAPSULE IS GIVEN ORALLY TO A PATIENT WHERE THE SODIUM IODIDE-131 IS ABSORBED RAPIDLY INTO THE BLOODSTREAM AND CONCENTRATES IN THE THYROID, WHERE IT IS INCORPORATED INTO HORMONES WHICH ARE STORED IN THE INTRAFOLLICULAR COLLOID. THE CAPSULE IS PRESENTED WITHIN A POLYCARBONATE CONTAINER WITH A CHARCOAL DISC TO ABSORB IODINE-131. THIS CONTAINER IS ENCLOSED WITHIN A LEAD SHIELD.

THIS IS A DIAGNOSTIC RADIO PHARMACEUTICAL CONTAINING IOFLUPANE-123. IT ALSO CONTAINS ACETIC ACID, SODIUM ACETATE, ETHANOL AND WATER. IT IS INJECTED INTO A PATIENT AND CARRIED BY THE BLOODSTREAM WHERE IT COLLECTS IN A SMALL AREA OF THE BRAIN. THE RADIOACTIVITY IS THEN DETECTED OUTSIDE THE BODY BY USING SPECIAL CAMERAS AND A PICTURE CAN BE TAKEN. THIS WILL SHOW LOSS OF FUNCTIONAL DOPAMINERGIC NUERON TERMINALS IN THE STRATIUM OF PATIENTS WITH CLINICALLY UNCERTAIN PARKINSONS SYNDROMES. THE MATERIAL IS SUPPLIED IN GLASS VIAL SEALED WITH A RUBBER CLOSURE AND METAL OVERSEAL.